摘要
目的探讨雌激素受体α(ERα)阳性的乳腺癌细胞中ERα对神经激肽受体-1截短型变异体(NK1R-Tr)的调控作用,以及ERα是否通过调控NK1R-Tr的表达,间接调控细胞的增殖能力。方法染色质免疫共沉淀(CHIP)实验验证ERα是否可以结合到NK1R-Tr启动子上游的ERα反应元件,直接调控NK1R-Tr的表达;荧光素酶报告基因实验验证ERα是否对NK1R-Tr的表达起正性调控作用。Western blot实验和RT-PCR实验检测乳腺癌细胞系MCF-7和T47D的ERα和NK1R-Tr在蛋白水平和m RNA水平的表达情况;以及在ERα激动剂雌二醇(E2)刺激的条件下,小干扰RNA敲除ERα后,NK1R-Tr在不同水平的表达情况;小干扰RNA敲除NK1R-Tr后,CCK-8和克隆形成实验检测敲除NK1R-Tr的乳腺癌细胞的增殖能力。结果在NK1R-Tr基因启动子上游存在ERα的反应元件,ERα在E2存在条件下作用于该反应元件,对NK1R-Tr的表达起正性调控作用。同样在E2刺激的条件下,敲除乳腺癌细胞MCF-7内源性ERα后,NK1R-Tr在蛋白水平和m RNA水平的表达均下降;且敲除NK1R-Tr的MCF-7细胞增殖能力较未敲除组明显降低。结论在ERα阳性的乳腺癌细胞中,ERα正性调控NK1R-Tr的表达,从而增强细胞的增殖能力。
To analyze the regulation of estrogen receptor α (ERα) on truncated neurokinin-1 receptor (NK1R-Tr), and the influence of this regulation on cell proliferation in estrogen receptor-positive breast cancer cell lines.Methods The chromatin immune coprecipitation (CHIP) was used to observe the transcriptional regulation function of ERαon NK1R- Tr in breast cancer cells. Luciferase reporter gene assay was used to verify whether ERα played a positiveregulatory role in the expression of NK1R-Tr. Western blot assay and real-time-PCR were used to detect the expression ofERα and NK1R-Tr in breast cancer cells, MCF-7 and T47D, as well as the expression of NK1R-Tr protein and mRNAlevel. NK1R-Tr levels were also detected after using estradiol (E2, ERα agonist) and small interfering RNA (knock outERα). CCK- 8 and clone formation experimen were used to detect the proliferation ability of breast cancer cells afterknocking out NK1R-Tr with small interfering RNAs. Results CHIP test and Luciferase reporter gene assay proved thatERα can positively regulate the expression of NK1R-Tr via the ERα sequences in the upstream of the NK1R-Tr genepromoter. The expression of NK1R-Tr at both protein level and mRNA level dropped in the estrogen receptor-positive breastcancer cell line MCF-7 upon knocking out ERα. After knocking out NK1R-Tr, the proliferation ability of estrogen receptorpositivebreast cancer cells was lower than that of the control group. Conclusion The ERα positively regulates the expression of NK1R-Tr, resulting in the increased cell proliferation in estrogen positive breast cancer cells.
作者
刘晓彬
仝颖娜
张露芳
周云丽
TONG Yingna;ZHANG Lufang;ZHOU Yunli(Department of Clinical Laboratory, Cancer Institute and Hospital, Tianjin Medical University, National Clinical Research Center of Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China)
出处
《天津医药》
CAS
2016年第12期1409-1413,共5页
Tianjin Medical Journal
基金
国家自然科学基金资助项目(81201653)